HOME
|
CONTACT US
|
INDEX
Our Company
Our Mission & Commitment
Key Facts
Leadership
Governance
History
Compliance & Ethics
Diversity & Inclusion
Our Websites
Achievements
Business Information
R&D
R&D Strategy
In the Pipeline
Disease Areas of Focus
Our R&D
Our Science
R&D Highlights
Major R&D Facilities
Clinical Trials
Products
Patient Assistance Programs
Prescribing Information
R&D
Clinical Trials
Counterfeit Drugs
Product Information Inquiries
News
Press Releases
Publications
Media Library
Key Facts
Leadership
Financial Reporting
Features
Achievements
Media Contacts
Subscribe to e-mail alerts
Investors
Key Facts
Stock Information
SEC Filings
Financial Reporting
Events & Presentations
Shareholder Services
Investor Contacts
Partnering
Why Partner With Us?
Areas of Interest
Our Process
Our Partners
Partnering News
Partnering Contact
Responsibility
Bristol-Myers Squibb Foundation
Sustainability
Patient Assistance Programs
Building Our Communities
Grants & Giving
Position on Key Issues
Clinical Trials
Combating Counterfeit Drugs
Achievements
Careers
Job Opportunities
Our Culture
Diversity & Inclusion
Developing Our People
University Recruitment
Achievements
Benefits
Manage My Profile
Apply Now
Sustainability
CEO Message
Global Reporting Initiative
Executive Summary
Sustainability Issues
2010 Goals and Key Indicators
Worldwide Facilities
Alphabetical
Region
Asia
Europe
Agen, France
Epernon, France
Fontenay, France
Meymac, France
Cruiserath, Ireland
Swords, Ireland
Anagni, Italy
Latina, Italy
Moreton, UK
North America
Latin America
Stakeholder Engagement
Governance and Management
Economic Responsibility
Social Progress
Environmental Performance
Go Green
Subject Index
Downloads
BMS.com Home
»
Sustainability
»
Worldwide Facilities
»
Europe
Europe
Europe
England
Moreton
France
Agen
Épernon
Fontenay
Meymac
Ireland
Cruiserath
Swords
Italy
Anagni
Latina